Translational Utility of Rodent Hippocampal Auditory Gating in Schizophrenia Research: a Review and Evaluation

Overview

Journal Transl Psychiatry

Specialties Psychiatry
Public Health

Date 2015 Jun 24

PMID 26101850

Citations 13

Authors

J Smucny

K E Stevens

A Olincy

J R Tregellas

Affiliations

Soon will be listed here.

Abstract

Impaired gating of the auditory evoked P50 potential is one of the most pharmacologically well-characterized features of schizophrenia. This deficit is most commonly modeled in rodents by implanted electrode recordings from the hippocampus of the rodent analog of the P50, the P20-N40. The validity and effectiveness of this tool, however, has not been systematically reviewed. Here, we summarize findings from studies that have examined the effects of pharmacologic modulation on gating of the rodent hippocampal P20-N40 and the human P50. We show that drug effects on the P20-N40 are highly predictive of human effects across similar dose ranges. Furthermore, mental status (for example, anesthetized vs alert) does not appear to diminish the predictive capacity of these recordings. We then discuss hypothesized neuropharmacologic mechanisms that may underlie gating effects for each drug studied. Overall, this review supports continued use of hippocampal P20-N40 gating as a translational tool for schizophrenia research.

Citing Articles

Neurophysiological Models in Individuals at Clinical High Risk for Psychosis: Using Translational EEG Paradigms to Forecast Psychosis Risk and Resilience.

Hamilton H, Mathalon D Adv Neurobiol. 2024; 40:385-410.

PMID: 39562452 DOI: 10.1007/978-3-031-69491-2_14.

Cholinergic modulation of sensory perception and plasticity.

Kunnath A, Gifford R, Wallace M Neurosci Biobehav Rev. 2023; 152:105323.

PMID: 37467908 PMC: 10424559. DOI: 10.1016/j.neubiorev.2023.105323.

Neurophysiology in psychosis: The quest for disease biomarkers.

Wang B, Zartaloudi E, Linden J, Bramon E Transl Psychiatry. 2022; 12(1):100.

PMID: 35277479 PMC: 8917164. DOI: 10.1038/s41398-022-01860-x.

Selective 5HT3 antagonists and sensory processing: a systematic review.

Tsitsipa E, Rogers J, Casalotti S, Belessiotis-Richards C, Zubko O, Weil R Neuropsychopharmacology. 2022; 47(4):880-890.

PMID: 35017671 PMC: 8882165. DOI: 10.1038/s41386-021-01255-4.

Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction.

Aguilar D, Radzik L, Schiffino F, Folorunso O, Zielinski M, Coyle J Sci Rep. 2021; 11(1):9031.

PMID: 33907230 PMC: 8079688. DOI: 10.1038/s41598-021-88428-9.

References

Miwa J, Freedman R, Lester H . Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron. 2011; 70(1):20-33. PMC: 4418790. DOI: 10.1016/j.neuron.2011.03.014. View

Hall W, Hando J, Darke S, Ross J . Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996; 91(1):81-7. DOI: 10.1046/j.1360-0443.1996.9118110.x. View

Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M . Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 2002; 59(12):1085-96. DOI: 10.1001/archpsyc.59.12.1085. View

Adler L, Gerhardt G, FRANKS R, Baker N, Nagamoto H, Drebing C . Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res. 1990; 31(3):297-309. DOI: 10.1016/0165-1781(90)90099-q. View

Freedman R, Waldo M, Nagamoto H . Elementary neuronal dysfunctions in schizophrenia. Schizophr Res. 1991; 4(2):233-43. DOI: 10.1016/0920-9964(91)90035-p. View

Adler L, Hoffer L, Nagamoto H, Waldo M, Kisley M, Giffith J . Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology. 1994; 10(4):249-57. DOI: 10.1038/npp.1994.28. View

Breese C, Lee M, Adams C, Sullivan B, Logel J, Gillen K . Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology. 2000; 23(4):351-64. DOI: 10.1016/S0893-133X(00)00121-4. View

Arango C, Summerfelt A, Buchanan R . Olanzapine effects on auditory sensory gating in schizophrenia. Am J Psychiatry. 2003; 160(11):2066-8. DOI: 10.1176/appi.ajp.160.11.2066. View

Abbott A . Schizophrenia: The drug deadlock. Nature. 2010; 468(7321):158-9. DOI: 10.1038/468158a. View

10.

Miller C, Freedman R . Medial septal neuron activity in relation to an auditory sensory gating paradigm. Neuroscience. 1993; 55(2):373-80. DOI: 10.1016/0306-4522(93)90506-b. View

11.

Weisser R, Weisbrod M, Roehrig M, Rupp A, Schroeder J, Scherg M . Is frontal lobe involved in the generation of auditory evoked P50?. Neuroreport. 2001; 12(15):3303-7. DOI: 10.1097/00001756-200110290-00031. View

12.

Zhang X, Liu L, Liu S, Hong X, Chen D, Xiu M . Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia. Am J Psychiatry. 2012; 169(9):974-81. DOI: 10.1176/appi.ajp.2012.11081289. View

13.

Adler L, Pachtman E, Franks R, Pecevich M, Waldo M, Freedman R . Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 1982; 17(6):639-54. View

14.

Li Q, Guo-Ross S, Lewis D, Turner D, White A, Wilson W . Dietary prenatal choline supplementation alters postnatal hippocampal structure and function. J Neurophysiol. 2003; 91(4):1545-55. DOI: 10.1152/jn.00785.2003. View

15.

Nagamoto H, Johnson R, Adler L, Egan M, Rose G, Freedman R . Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol Psychiatry. 1990; 27(2):183-92. DOI: 10.1016/0006-3223(90)90648-l. View

16.

Minneman K, Esbenshade T . Alpha 1-adrenergic receptor subtypes. Annu Rev Pharmacol Toxicol. 1994; 34:117-33. DOI: 10.1146/annurev.pa.34.040194.001001. View

17.

Sargent P . The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci. 1993; 16:403-43. DOI: 10.1146/annurev.ne.16.030193.002155. View

18.

Crook J, Tomaskovic-Crook E, Copolov D, Dean B . Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry. 2001; 158(6):918-25. DOI: 10.1176/appi.ajp.158.6.918. View

19.

Gallinat J, Mulert C, Bajbouj M, Herrmann W, Schunter J, Senkowski D . Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage. 2002; 17(1):110-27. DOI: 10.1006/nimg.2002.1213. View

20.

Stevens K, Fuller L, Rose G . Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res. 1991; 555(1):91-8. DOI: 10.1016/0006-8993(91)90864-r. View